Ligand profile
Q3J
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_2710 — blc outer membrane lipoprotein
Identifiers
Database identifiers and provenance.
- Ligand ID
Q3J- PDB
6ubo- UniProt (similar protein)
P0A901- Target protein
- VK055_2710
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 26.6
- −1 ≤ LogP ≤ 5 1.88
- MW ≤ 500 Da 319.2
- LogP ≤ 5 1.88
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 26.6
Matches PAINS filter: anil_di_alk_B(251). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
[B-]1(c2cc(ccc2C=C3[N+]1=C(N(C3=O)C)C)N(CC)CC)(F)F[B-]1(c2cc(ccc2C=C3[N+]1=C(N(C3=O)C)C)N(CC)CC)(F)F
InChI=1S/C16H20BF2N3O/c1-5-21(6-2)13-8-7-12-9-15-16(23)20(4)11(3)22(15)17(18,19)14(12)10-13/h7-10H,5-6H2,1-4H3InChI=1S/C16H20BF2N3O/c1-5-21(6-2)13-8-7-12-9-15-16(23)20(4)11(3)22(15)17(18,19)14(12)10-13/h7-10H,5-6H2,1-4H3
OOEJBECJAKZKRT-UHFFFAOYSA-NOOEJBECJAKZKRT-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF08212
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand Q3J →
- PDB RCSB structure 6ubo →
- UniProt UniProt P0A901 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “Q3J”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2710.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).